These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1490 related articles for article (PubMed ID: 38038007)

  • 1. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.
    Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK
    Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Status of Alzheimer's Disease and Pathological Mechanisms Investigating the Therapeutic Molecular Targets.
    Bagga S; Kumar M
    Curr Mol Med; 2023; 23(6):492-508. PubMed ID: 35379149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
    Nagu P; Parashar A; Behl T; Mehta V
    J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
    Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
    Elife; 2020 Mar; 9():. PubMed ID: 32228858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevating the Levels of Calcium Ions Exacerbate Alzheimer's Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau.
    Guan PP; Cao LL; Wang P
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs.
    Thakral S; Yadav A; Singh V; Kumar M; Kumar P; Narang R; Sudhakar K; Verma A; Khalilullah H; Jaremko M; Emwas AH
    Ageing Res Rev; 2023 Jul; 88():101960. PubMed ID: 37224884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform.
    Kolaj I; Imindu Liyanage S; Weaver DF
    Neurochem Int; 2018 Nov; 120():99-111. PubMed ID: 30098379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the Pathophysiology of Alzheimer's Disease and Potential Therapeutic Targets: A Current Perspective.
    Rajah Kumaran K; Yunusa S; Perimal E; Wahab H; Müller CP; Hassan Z
    J Alzheimers Dis; 2023; 91(2):507-530. PubMed ID: 36502321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology.
    Esteras N; Abramov AY
    Cells; 2020 Sep; 9(9):. PubMed ID: 32967303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology of Alzheimer's Disease.
    Trejo-Lopez JA; Yachnis AT; Prokop S
    Neurotherapeutics; 2022 Jan; 19(1):173-185. PubMed ID: 34729690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances Towards Diagnosis and Therapeutic Fingerprinting for Alzheimer's Disease.
    Pradhan LK; Sahoo PK; Chauhan S; Das SK
    J Mol Neurosci; 2022 Jun; 72(6):1143-1165. PubMed ID: 35553375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Tau and Amyloid-β Targeted Immunotherapy Nanoparticles for Alzheimer's Disease.
    Mashal Y; Abdelhady H; Iyer AK
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinflammation in pathogenesis of Alzheimer's disease: Phytochemicals as potential therapeutics.
    Vaiserman A; Koliada A; Lushchak O
    Mech Ageing Dev; 2020 Jul; 189():111259. PubMed ID: 32450086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
    Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA in Alzheimer's disease revisited: implications for major neuropathological mechanisms.
    Dehghani R; Rahmani F; Rezaei N
    Rev Neurosci; 2018 Feb; 29(2):161-182. PubMed ID: 28941357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-coding RNAs in Regulation of Protein Aggregation and Clearance Pathways: Current Perspectives Towards Alzheimer's Research and Therapy.
    Sundram S; Dhiman N; Malviya R; Awasthi R
    Curr Gene Ther; 2024; 24(1):8-16. PubMed ID: 37519207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies.
    Kaur D; Behl T; Sehgal A; Singh S; Sharma N; Bungau S
    Neurochem Res; 2021 Nov; 46(11):2832-2851. PubMed ID: 34357520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 75.